Skip to main content

Juvenile idiopathic inflammatory myopathies assessment by magnetic resonance imaging: a scoping review of protocols, scoring systems, and applications.

Publication ,  Journal Article
Paula, VT; Omori, CH; Shinjo, SK; Araújo, DBD; Day, J; Schiffenbauer, A; Magalhães, CS; Conticini, E; Marrani, E; Guimarães, JB; Rider, LG ...
Published in: Adv Rheumatol
November 21, 2025

BACKGROUND:: Our review assessed whole body (WB) and dedicated body-part magnetic resonance imaging (DedMRI) techniques, protocols, and inflammatory scoring systems, focusing on their clinimetric properties (reliability, validity, responsiveness) in clinical and research settings of patients with juvenile idiopathic inflammatory myopathies (JIIM). METHODS:: A comprehensive search of MEDLINE, EMBASE, and Cochrane databases from 2000 to 2024 identified relevant studies. RESULTS:: Sixteen studies enrolling JIIM patients with MRI were reviewed, which showed heterogeneity in objectives, methodologies, and scoring systems. Four (25%) studies used quantitative assessments, while 12 (75%) employed semi-quantitative or qualitative methods in scoring MRI. WB-MRI was performed in 3 (18.7%) studies, and DedMRI in 13 (81.2%). Muscle evaluation included assessments of edema [14 (87.5%) studies], fatty infiltration [4 (25%) studies], and atrophy [6 (37.5%) studies]. T1 images were used in 9 (56.2%) studies for measuring chronic changes, with coronal views reported in 6 (37.5%). Fluid-sensitive sequences (T2 with fat saturation, STIR) were employed in all studies and were obtained in the coronal plane in 9 (56.2%). These sequences were crucial for detecting soft tissue edema related to acute/subacute inflammation. One (6%) study included diffusion and T1 post-contrast sequences. CONCLUSION:: There is significant heterogeneity in MRI protocols for evaluating JIIM. Standardized WB-MRI protocols are needed to ensure consistency and comparability across studies and institutions, optimize assessments of disease activity, treatment response, and follow-up in JIIM patients. Standardization should enhance the reliability of MRI for diagnosing and monitoring JIIM in clinical and research settings.

Duke Scholars

Published In

Adv Rheumatol

DOI

EISSN

2523-3106

Publication Date

November 21, 2025

Volume

65

Issue

1

Start / End Page

64

Location

England
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Paula, V. T., Omori, C. H., Shinjo, S. K., Araújo, D. B. D., Day, J., Schiffenbauer, A., … IMACS WBMRI in Myopathies Working Group. (2025). Juvenile idiopathic inflammatory myopathies assessment by magnetic resonance imaging: a scoping review of protocols, scoring systems, and applications. Adv Rheumatol, 65(1), 64. https://doi.org/10.1186/s42358-025-00494-z
Paula, Vitor Tavares, Clarissa Harumi Omori, Samuel Katsuyuki Shinjo, Daniel Brito de Araújo, Jessica Day, Adam Schiffenbauer, Claudia Saad Magalhães, et al. “Juvenile idiopathic inflammatory myopathies assessment by magnetic resonance imaging: a scoping review of protocols, scoring systems, and applications.Adv Rheumatol 65, no. 1 (November 21, 2025): 64. https://doi.org/10.1186/s42358-025-00494-z.
Paula VT, Omori CH, Shinjo SK, Araújo DBD, Day J, Schiffenbauer A, et al. Juvenile idiopathic inflammatory myopathies assessment by magnetic resonance imaging: a scoping review of protocols, scoring systems, and applications. Adv Rheumatol. 2025 Nov 21;65(1):64.
Paula, Vitor Tavares, et al. “Juvenile idiopathic inflammatory myopathies assessment by magnetic resonance imaging: a scoping review of protocols, scoring systems, and applications.Adv Rheumatol, vol. 65, no. 1, Nov. 2025, p. 64. Pubmed, doi:10.1186/s42358-025-00494-z.
Paula VT, Omori CH, Shinjo SK, Araújo DBD, Day J, Schiffenbauer A, Magalhães CS, Conticini E, Marrani E, Guimarães JB, Rider LG, Essouma M, Appenzeller S, Doria AS, Elias AM, IMACS WBMRI in Myopathies Working Group. Juvenile idiopathic inflammatory myopathies assessment by magnetic resonance imaging: a scoping review of protocols, scoring systems, and applications. Adv Rheumatol. 2025 Nov 21;65(1):64.

Published In

Adv Rheumatol

DOI

EISSN

2523-3106

Publication Date

November 21, 2025

Volume

65

Issue

1

Start / End Page

64

Location

England